The Kaposi's-sarcoma-associated herpesvirus orf35 gene product is required for efficient lytic virus reactivation.

MLA

Bergson, Shir, et al. “The Kaposi’s-Sarcoma-Associated Herpesvirus Orf35 Gene Product Is Required for Efficient Lytic Virus Reactivation.” Virology, vol. 499, Dec. 2016, pp. 91–98. EBSCOhost, https://doi.org/10.1016/j.virol.2016.09.008.

APA

Bergson, S., Itzhak, I., Wasserman, T., Gelgor, A., Kalt, I., & Sarid, R. (2016). The Kaposi’s-sarcoma-associated herpesvirus orf35 gene product is required for efficient lytic virus reactivation. Virology, 499, 91–98. https://doi.org/10.1016/j.virol.2016.09.008

Chicago

Bergson, Shir, Inbal Itzhak, Talya Wasserman, Anastasia Gelgor, Inna Kalt, and Ronit Sarid. 2016. “The Kaposi’s-Sarcoma-Associated Herpesvirus Orf35 Gene Product Is Required for Efficient Lytic Virus Reactivation.” Virology 499 (December): 91–98. doi:10.1016/j.virol.2016.09.008.